Evidence map›Paper›PMID 41657732›Full record

ReviewFrontiers in medical technology2026

IoMT-Fog-Cloud-based AI frameworks for chronic disease diagnosis: updated comparative analysis with recent AI-IoMT models (2020-2025).

Kitsakorn Locharoenrat

Abstract readReview
In one paragraph

Review in Frontiers in medical technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Kitsakorn LocharoenratDepartment of Physics, School of Science, King Mongkut's Institute of Technology Ladkrabang, Bangkok, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic diseases such as diabetes and cardiovascular disease require frequent monitoring and timely clinical feedback to prevent complications. Internet of Medical Things (IoMT) systems increasingly combine near-patient sensing with Fog and Cloud computing so that time-critical preprocessing and inference can run close to the patient while compute-intensive training and population-level analytics remain in the Cloud. This review synthesizes primary studies published between 2020 and 2025 that implement AI-enabled IoMT, with an emphasis on systems that report both diagnostic performance and network quality-of-service (QoS). Following PRISMA 2020, we screened database records and included 14 primary studies; we focus the joint performance-QoS synthesis on six IoMT-Fog-Cloud frameworks for diabetes and cardiovascular disease and compare them with two recent multi-disease AI-IoMT models (DACL and TasLA). Diabetes-oriented implementations commonly report accuracy around 95%-96% using explainable or ensemble deep learning, whereas some cardiovascular frameworks report >99% accuracy in controlled settings; we therefore discuss plausible sources of optimistic performance, including small datasets, class imbalance, curated benchmarks, and potential leakage/overfitting in simulation-based evaluations. Across IoMT-Fog-Cloud studies, placing preprocessing and/or inference at the Fog layer repeatedly reduces end-to-end latency for streaming biosignals, but multi-Fog provisioning can increase energy and power demands. To support more reproducible comparisons, we organize 14 extracted metrics into (i) diagnostic performance (accuracy, precision, recall, F1-score, sensitivity, specificity) and (ii) system/network QoS (latency, jitter, throughput, bandwidth utilization, processing/execution time, network usage, energy consumption, power consumption), and we translate the evidence into study-linked design recommendations for future deployments.

Indexed as

chronic disease diagnosiscloud computingdeep learningfog computinginternet of Medical Things (IoMT)network performance

Identifiers

PMID41657732
PMCPMC12872747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.